je.st
news
Tag: pills
Proxy Fights, Poison Pills, and Pushy Suitors: What You Need to Know about Hostile Takeovers
2016-03-03 18:38:59| Food - Topix.net
This is the third of a three-part series on mergers and acquisitions. Click here to learn the seven things all investors should know about M&A and find out here the five biggest M&A deals of all time.
Tags: proxy
poison
pills
hostile
Proxy Fights, Poison Pills, and Pushy Suitors: What You Need to Know about Hostile Takeovers
2016-03-03 18:13:53| Beverages - Topix.net
This is the third of a three-part series on mergers and acquisitions. Click here to learn the seven things all investors should know about M&A and find out here the five biggest M&A deals of all time.
Tags: proxy
poison
pills
hostile
XiMo and Aspira Scientific Launch Air-Stable Metathesis Pills
2015-10-16 12:31:14| Industrial Newsroom - All News for Today
Delivering Nobel-Winning Catalysis Platform for Rapid Pharmaceutical R&D Screening SAN FRANCISCO, XiMo AG (Lucerne, Switzerland) and Aspira Scientific, Inc. (Milpitas, California) announced today the launch of air-stable catalyst pills (CatPac's) for metathesis chemistry. The importance of metathesis chemistry...
Tags: scientific
launch
pills
aspira
Diabetes pill's added bonus is protection from heart attacks
2015-09-17 19:56:49| Food - Topix.net
A diabetes pill called Jardiance cut deaths from heart attacks and strokes in thousands of patients, the first drug to show promise in helping subdue two of the world's most rampant health epidemics. The medicine, sold by Eli Lilly and Boehringer Ingelheim, reduced the risk of heart attacks, strokes and cardiovascular deaths by 14 percent in a study of 7,020 people with adult-onset diabetes and a high risk of heart problems.
Tags: added
heart
protection
bonus
Diabetes pill's added bonus is protection from heart attacks
2015-09-17 19:41:49| Agriculture - Topix.net
A diabetes pill called Jardiance cut deaths from heart attacks and strokes in thousands of patients, the first drug to show promise in helping subdue two of the world's most rampant health epidemics. The medicine, sold by Eli Lilly and Boehringer Ingelheim, reduced the risk of heart attacks, strokes and cardiovascular deaths by 14 percent in a study of 7,020 people with adult-onset diabetes and a high risk of heart problems.
Tags: added
heart
protection
bonus